You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

List of Excipients in API ADAPALENE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ADAPALENE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Galderma Laboratories LP DIFFERIN adapalene 0299-4910 CARBOMER HOMOPOLYMER TYPE C
Galderma Laboratories LP DIFFERIN adapalene 0299-4910 EDETATE DISODIUM
Galderma Laboratories LP DIFFERIN adapalene 0299-4910 HYDROCHLORIC ACID
Galderma Laboratories LP DIFFERIN adapalene 0299-4910 METHYLPARABEN
Galderma Laboratories LP DIFFERIN adapalene 0299-4910 POLOXAMER 182
Galderma Laboratories LP DIFFERIN adapalene 0299-4910 PROPYLENE GLYCOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Try a Trial

Excipients in ANDA-approved (generic) drugs containing ADAPALENE

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc adapalene 0093-6301 CARBOMER HOMOPOLYMER TYPE C
Teva Pharmaceuticals USA Inc adapalene 0093-6301 EDETATE DISODIUM
Teva Pharmaceuticals USA Inc adapalene 0093-6301 HYDROCHLORIC ACID
Teva Pharmaceuticals USA Inc adapalene 0093-6301 METHYLPARABEN
Teva Pharmaceuticals USA Inc adapalene 0093-6301 POLOXAMER 182
Teva Pharmaceuticals USA Inc adapalene 0093-6301 PROPYLENE GLYCOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Try a Trial

Detailed excipient profiles for ADAPALENE

Excipient focus: ACRYLIC ACID/SODIUM ACRYLATE COPOLYMER

Excipient focus: ALCOHOL

Excipient focus: CARBOMER 934

Excipient focus: CARBOMER HOMOPOLYMER TYPE A

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

Excipient focus: CARBOMER HOMOPOLYMER TYPE C

Excipient focus: CARBOXYPOLYMETHYLENE

Excipient focus: CYCLOMETHICONE

Excipient focus: DOCUSATE SODIUM

ADAPALENE drug variants containing DOCUSATE SODIUM

Company Ingredient NDC
TEVA PHARMACEUTICALS USA INC adapalene and benzoyl peroxide 0093-6303
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5906
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5908
Sandoz Inc adapalene and benzoyl peroxide 0781-7182
Padagis Israel Pharmaceuticals Ltd adapalene and benzoyl peroxide 45802-846
Padagis Israel Pharmaceuticals Ltd adapalene and benzoyl peroxide 45802-853
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: EDETATE DISODIUM

Excipient focus: EDETATE SODIUM

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: ISOHEXADECANE

ADAPALENE drug variants containing ISOHEXADECANE

Company Ingredient NDC
TEVA PHARMACEUTICALS USA INC adapalene and benzoyl peroxide 0093-6303
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5906
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5908
Padagis Israel Pharmaceuticals Ltd adapalene and benzoyl peroxide 45802-846
Padagis Israel Pharmaceuticals Ltd adapalene and benzoyl peroxide 45802-853
Physicians Total Care Inc adapalene and benzoyl peroxide 54868-5991
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: LIMONENE

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHYL GLUCOSE SESQUISTEARATE

Excipient focus: METHYLPARABEN

ADAPALENE drug variants not containing METHYLPARABEN

Company Ingredient NDC
Alchemee LLC adapalene 11410-958
CALL INC (dba Rochester Pharmaceuticals) adapalene 49908-118
Taro Pharmaceuticals USA Inc adapalene 51672-2150
TEVA PHARMACEUTICALS USA INC adapalene and benzoyl peroxide 0093-6303
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5906
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5908
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: PEG-20 METHYL GLUCOSE SESQUISTEARATE

Excipient focus: PHENOXYETHANOL

Excipient focus: POLOXAMER 124

ADAPALENE drug variants containing POLOXAMER 124

Company Ingredient NDC
TEVA PHARMACEUTICALS USA INC adapalene and benzoyl peroxide 0093-6303
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5906
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5908
Galderma Laboratories LP adapalene 0299-5912
Galderma Laboratories LP adapalene 0299-5918
Padagis Israel Pharmaceuticals Ltd adapalene and benzoyl peroxide 45802-846
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: POLOXAMER 182

Excipient focus: POLYETHYLENE GLYCOL 1500

Excipient focus: POLYETHYLENE GLYCOL 300

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYSORBATE 80

ADAPALENE drug variants containing POLYSORBATE 80

Company Ingredient NDC
TEVA PHARMACEUTICALS USA INC adapalene and benzoyl peroxide 0093-6303
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5906
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5908
Sandoz Inc adapalene and benzoyl peroxide 0781-7182
Padagis Israel Pharmaceuticals Ltd adapalene and benzoyl peroxide 45802-846
Padagis Israel Pharmaceuticals Ltd adapalene and benzoyl peroxide 45802-853
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SODIUM ACRYLATE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER

ADAPALENE drug variants not containing SODIUM ACRYLATE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER

Company Ingredient NDC
Teva Pharmaceuticals USA Inc adapalene 0093-6301
E Fougera & Co a division of Fougera Pharmaceuticals Inc adapalene 0168-0424
Galderma Laboratories LP adapalene 0299-4910
Galderma Laboratories LP adapalene 0299-5912
GALDERMA LABORATORIES LP adapalene 0299-5915
Galderma Laboratories LP adapalene 0299-5918
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: SODIUM ACRYLOYLDIMETHYLTAURATE-ACRYLAMIDE COPOLYMER

ADAPALENE drug variants not containing SODIUM ACRYLOYLDIMETHYLTAURATE-ACRYLAMIDE COPOLYMER

Company Ingredient NDC
Teva Pharmaceuticals USA Inc adapalene 0093-6301
E Fougera & Co a division of Fougera Pharmaceuticals Inc adapalene 0168-0424
Galderma Laboratories LP adapalene 0299-4910
Galderma Laboratories LP adapalene 0299-5912
GALDERMA LABORATORIES LP adapalene 0299-5915
Galderma Laboratories LP adapalene 0299-5918
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SORBITAN MONOOLEATE

ADAPALENE drug variants containing SORBITAN MONOOLEATE

Company Ingredient NDC
TEVA PHARMACEUTICALS USA INC adapalene and benzoyl peroxide 0093-6303
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5906
Galderma Laboratories LP adapalene and benzoyl peroxide 0299-5908
Sandoz Inc adapalene and benzoyl peroxide 0781-7182
Padagis Israel Pharmaceuticals Ltd adapalene and benzoyl peroxide 45802-846
Padagis Israel Pharmaceuticals Ltd adapalene and benzoyl peroxide 45802-853
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: SQUALANE

Excipient focus: SQUALENE

Excipient focus: STEARYL ALCOHOL

Excipient focus: TROLAMINE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - HIPAA-ready chat for life sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group